Miklos D Kertai1, Jonathan D Mosley2, Jing He3, Abinaya Ramakrishnan4, Mark J Abdelmalak4, Yurim Hong4, M Benjamin Shoemaker5, Dan M Roden2,3,6, Lisa Bastarache3. 1. Departments of Anesthesiology (M.D.K.), Vanderbilt University Medical Center, Nashville, TN. 2. Medicine (J.D.M., D.M.R.), Vanderbilt University Medical Center, Nashville, TN. 3. Biomedical Informatics (J.H., L.B., D.M.R.), Vanderbilt University Medical Center, Nashville, TN. 4. Vanderbilt University, Nashville, TN (A.R., M.A., Y.H.). 5. Division of Cardiovascular Medicine, Nashville VA Medical Center and Vanderbilt University, TN (M.B.S.). 6. Pharmacology (D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Abstract
BACKGROUND: Postoperative atrial fibrillation (PoAF) remains a significant risk factor for increased morbidity and mortality after cardiac surgery. The ability to accurately identify patients at risk through clinical risk factors is limited. There is growing evidence that polygenic risk contributes significantly to PoAF and incorporating measures of genetic risk could enhance prediction. METHODS: A retrospective cohort study of 1047 patients of White European ancestry who underwent either coronary artery bypass grafting or valve surgery at a tertiary academic center and were free from a history or persistent preoperative atrial fibrillation. The primary outcome was defined as PoAF based on postoperative ECG reports, medical record documentation, and changes in medication. The exposure was a polygenic risk score (PRS) comprising 2746 single-nucleotide polymorphisms previously associated with atrial fibrillation risk. The prediction of PoAF risk was assessed using measures of model discrimination, calibration, and net reclassification improvement. RESULTS: A total of 259 patients (24.7%) developed PoAF. The PRS was significantly associated with a higher risk for PoAF (odds ratio, 1.63 per SD increase in PRS [95% CI, 1.41-1.90]). Addition of PRS to patient- and procedure-related predictors of PoAF significantly increased the C statistic from 0.742 to 0.782 (change in C statistic, 0.040 [95% CI, 0.021-0.060]) while maintaining good calibration. The addition of the PRS to patient- and procedure-related predictors of PoAF improved model fit (likelihood ratio test, P=2.8×10-15) and significantly improved measures of reclassification (net reclassification improvement, 0.158 [95% CI, 0.066-0.274]). CONCLUSIONS: The PRS for PoAF was associated with improved discrimination, calibration, and risk reclassification compared with conventional clinical predictors suggesting that a PoAF PRS may enhance risk prediction of PoAF in patients undergoing coronary artery bypass grafting or valve surgery.
BACKGROUND: Postoperative atrial fibrillation (PoAF) remains a significant risk factor for increased morbidity and mortality after cardiac surgery. The ability to accurately identify patients at risk through clinical risk factors is limited. There is growing evidence that polygenic risk contributes significantly to PoAF and incorporating measures of genetic risk could enhance prediction. METHODS: A retrospective cohort study of 1047 patients of White European ancestry who underwent either coronary artery bypass grafting or valve surgery at a tertiary academic center and were free from a history or persistent preoperative atrial fibrillation. The primary outcome was defined as PoAF based on postoperative ECG reports, medical record documentation, and changes in medication. The exposure was a polygenic risk score (PRS) comprising 2746 single-nucleotide polymorphisms previously associated with atrial fibrillation risk. The prediction of PoAF risk was assessed using measures of model discrimination, calibration, and net reclassification improvement. RESULTS: A total of 259 patients (24.7%) developed PoAF. The PRS was significantly associated with a higher risk for PoAF (odds ratio, 1.63 per SD increase in PRS [95% CI, 1.41-1.90]). Addition of PRS to patient- and procedure-related predictors of PoAF significantly increased the C statistic from 0.742 to 0.782 (change in C statistic, 0.040 [95% CI, 0.021-0.060]) while maintaining good calibration. The addition of the PRS to patient- and procedure-related predictors of PoAF improved model fit (likelihood ratio test, P=2.8×10-15) and significantly improved measures of reclassification (net reclassification improvement, 0.158 [95% CI, 0.066-0.274]). CONCLUSIONS: The PRS for PoAF was associated with improved discrimination, calibration, and risk reclassification compared with conventional clinical predictors suggesting that a PoAF PRS may enhance risk prediction of PoAF in patients undergoing coronary artery bypass grafting or valve surgery.
Entities:
Keywords:
atrial fibrillation; calibration; general surgery; likelihood functions; thoracic surgery
Authors: Mihai V Podgoreanu; Joseph P Mathew; Miklos D Kertai; Yen-Wei Li; Yi-Ju Li; Svati H Shah; William E Kraus; Manuel L Fontes; Mark Stafford-Smith; Mark F Newman Journal: Circ Cardiovasc Genet Date: 2014-07-21
Authors: Steven A Lubitz; Kathryn L Lunetta; Honghuang Lin; Dan E Arking; Stella Trompet; Guo Li; Bouwe P Krijthe; Daniel I Chasman; John Barnard; Marcus E Kleber; Marcus Dörr; Kouichi Ozaki; Albert V Smith; Martina Müller-Nurasyid; Stefan Walter; Joanne M Murabito; Moritz F Sinner; Vilmundur Gudnason; Stephan B Felix; Winfried März; Mina Chung; Christine M Albert; Bruno H Stricker; Toshihiro Tanaka; Susan R Heckbert; J Wouter Jukema; Alvaro Alonso; Emelia J Benjamin; Patrick T Ellinor; Sunil K Agarwal; Joshua C Bis; Jennifer A Brody; Lin Y Chen; Brendan M Everett; Ian Ford; Oscar H Franco; Tamara B Harris; Albert Hofman; Stefan Kääb; Saagar Mahida; Sekar Kathiresan; Michiaki Kubo; Lenore J Launer; Peter W MacFarlane; Jared W Magnani; Barbara McKnight; David D McManus; Annette Peters; Bruce M Psaty; Lynda M Rose; Jerome I Rotter; Guenther Silbernagel; Jonathan D Smith; Nona Sotoodehnia; David J Stott; Kent D Taylor; Andreas Tomaschitz; Tatsuhiko Tsunoda; Andre G Uitterlinden; David R Van Wagoner; Uwe Völker; Henry Völzke Journal: J Am Coll Cardiol Date: 2014-01-30 Impact factor: 24.094
Authors: George Thanassoulis; Gina M Peloso; Michael J Pencina; Udo Hoffmann; Caroline S Fox; L Adrienne Cupples; Daniel Levy; Ralph B D'Agostino; Shih-Jen Hwang; Christopher J O'Donnell Journal: Circ Cardiovasc Genet Date: 2012-01-10
Authors: Miklos D Kertai; Yi-Ju Li; Yunqi Ji; Wenjing Qi; Frederick W Lombard; Svati H Shah; William E Kraus; Mark Stafford-Smith; Mark F Newman; Carmelo A Milano; Nathan Waldron; Mihai V Podgoreanu; Joseph P Mathew Journal: Am Heart J Date: 2015-06-17 Impact factor: 4.749
Authors: Joshua Elliott; Barbara Bodinier; Tom A Bond; Marc Chadeau-Hyam; Evangelos Evangelou; Karel G M Moons; Abbas Dehghan; David C Muller; Paul Elliott; Ioanna Tzoulaki Journal: JAMA Date: 2020-02-18 Impact factor: 56.272
Authors: Simon C Body; Charles D Collard; Stanton K Shernan; Amanda A Fox; Kuang-Yu Liu; Marylyn D Ritchie; Tjörvi E Perry; Jochen D Muehlschlegel; Sary Aranki; Brian S Donahue; Mias Pretorius; Juan-Carlos Estrada; Patrick T Ellinor; Christopher Newton-Cheh; Christine E Seidman; J G Seidman; Daniel S Herman; Peter Lichtner; Thomas Meitinger; Arne Pfeufer; Stefan Kääb; Nancy J Brown; Dan M Roden; Dawood Darbar Journal: Circ Cardiovasc Genet Date: 2009-08-02
Authors: Shane McCarthy; Sayantan Das; Warren Kretzschmar; Olivier Delaneau; Andrew R Wood; Alexander Teumer; Hyun Min Kang; Christian Fuchsberger; Petr Danecek; Kevin Sharp; Yang Luo; Carlo Sidore; Alan Kwong; Nicholas Timpson; Seppo Koskinen; Scott Vrieze; Laura J Scott; He Zhang; Anubha Mahajan; Jan Veldink; Ulrike Peters; Carlos Pato; Cornelia M van Duijn; Christopher E Gillies; Ilaria Gandin; Massimo Mezzavilla; Arthur Gilly; Massimiliano Cocca; Michela Traglia; Andrea Angius; Jeffrey C Barrett; Dorrett Boomsma; Kari Branham; Gerome Breen; Chad M Brummett; Fabio Busonero; Harry Campbell; Andrew Chan; Sai Chen; Emily Chew; Francis S Collins; Laura J Corbin; George Davey Smith; George Dedoussis; Marcus Dorr; Aliki-Eleni Farmaki; Luigi Ferrucci; Lukas Forer; Ross M Fraser; Stacey Gabriel; Shawn Levy; Leif Groop; Tabitha Harrison; Andrew Hattersley; Oddgeir L Holmen; Kristian Hveem; Matthias Kretzler; James C Lee; Matt McGue; Thomas Meitinger; David Melzer; Josine L Min; Karen L Mohlke; John B Vincent; Matthias Nauck; Deborah Nickerson; Aarno Palotie; Michele Pato; Nicola Pirastu; Melvin McInnis; J Brent Richards; Cinzia Sala; Veikko Salomaa; David Schlessinger; Sebastian Schoenherr; P Eline Slagboom; Kerrin Small; Timothy Spector; Dwight Stambolian; Marcus Tuke; Jaakko Tuomilehto; Leonard H Van den Berg; Wouter Van Rheenen; Uwe Volker; Cisca Wijmenga; Daniela Toniolo; Eleftheria Zeggini; Paolo Gasparini; Matthew G Sampson; James F Wilson; Timothy Frayling; Paul I W de Bakker; Morris A Swertz; Steven McCarroll; Charles Kooperberg; Annelot Dekker; David Altshuler; Cristen Willer; William Iacono; Samuli Ripatti; Nicole Soranzo; Klaudia Walter; Anand Swaroop; Francesco Cucca; Carl A Anderson; Richard M Myers; Michael Boehnke; Mark I McCarthy; Richard Durbin Journal: Nat Genet Date: 2016-08-22 Impact factor: 38.330
Authors: Mike Thompson; Brian L Hill; Nadav Rakocz; Jeffrey N Chiang; Daniel Geschwind; Sriram Sankararaman; Ira Hofer; Maxime Cannesson; Noah Zaitlen; Eran Halperin Journal: NPJ Genom Med Date: 2022-08-25 Impact factor: 6.083